218 related articles for article (PubMed ID: 31112524)
21. Non-homologous end-joining genes are not inactivated in human radiation-induced sarcomas with genomic instability.
Lefèvre SH; Coquelle A; Gonin-Laurent N; Cör A; Vogt N; Chauveinc L; Anract P; Dutrillaux B; Chevillard S; Malfoy B
J Radiat Res; 2005 Jun; 46(2):223-31. PubMed ID: 15988141
[TBL] [Abstract][Full Text] [Related]
22. The Kras mutational spectra of chemically induced lung tumors in different inbred mice mimics the spectra of KRAS mutations in adenocarcinomas in smokers versus nonsmokers.
Fritz JM; Dwyer-Nield LD; Russell BM; Malkinson AM
J Thorac Oncol; 2010 Feb; 5(2):254-7. PubMed ID: 20101149
[TBL] [Abstract][Full Text] [Related]
23. Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation.
McKinnon T; Venier R; Dickson BC; Kabaroff L; Alkema M; Chen L; Shern JF; Yohe ME; Khan J; Gladdy RA
Oncotarget; 2015 Jun; 6(16):14220-32. PubMed ID: 25992772
[TBL] [Abstract][Full Text] [Related]
24. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
[TBL] [Abstract][Full Text] [Related]
26. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
Hulla JE; French JE; Dunnick JK
Carcinogenesis; 2001 Jan; 22(1):89-98. PubMed ID: 11159746
[TBL] [Abstract][Full Text] [Related]
28. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
Brachman DG; Hallahan DE; Beckett MA; Yandell DW; Weichselbaum RR
Cancer Res; 1991 Dec; 51(23 Pt 1):6393-6. PubMed ID: 1933904
[TBL] [Abstract][Full Text] [Related]
29. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas.
Nasir L; Rutteman GR; Reid SW; Schulze C; Argyle DJ
Cancer Lett; 2001 Dec; 174(1):83-9. PubMed ID: 11675155
[TBL] [Abstract][Full Text] [Related]
30. Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.
Pérot G; Chibon F; Montero A; Lagarde P; de Thé H; Terrier P; Guillou L; Ranchère D; Coindre JM; Aurias A
Am J Pathol; 2010 Oct; 177(4):2080-90. PubMed ID: 20884963
[TBL] [Abstract][Full Text] [Related]
31. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
32. Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden.
Raj SKS; Routh ED; Chou JW; Votanopoulos KI; Triozzi PL; Miller LD
Cancer; 2022 Sep; 128(17):3254-3264. PubMed ID: 35767280
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic changes in murine lymphoid tumors induced by in utero exposure to ionizing radiation.
Lumniczky K; Antal S; Unger E; Hidvégi EJ; Sáfrány G
Radiat Oncol Investig; 1997; 5(3):158-62. PubMed ID: 9303076
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathogenesis of transplacentally induced mouse lung tumors.
Miller MS; Leone-Kabler S; Rollins LA; Wessner LL; Fan M; Schaeffer DO; McEntee MF; O'Sullivan MG
Exp Lung Res; 1998; 24(4):557-77. PubMed ID: 9659583
[TBL] [Abstract][Full Text] [Related]
35. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.
Stanley LA
Toxicology; 1995 Feb; 96(3):173-94. PubMed ID: 7900159
[TBL] [Abstract][Full Text] [Related]
36. Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.
Nepal C; O'Rourke CJ; Oliveira DVNP; Taranta A; Shema S; Gautam P; Calderaro J; Barbour A; Raggi C; Wennerberg K; Wang XW; Lautem A; Roberts LR; Andersen JB
Hepatology; 2018 Sep; 68(3):949-963. PubMed ID: 29278425
[TBL] [Abstract][Full Text] [Related]
37. Ki-ras mutations in spontaneous and chemically induced renal tumors of the rat.
Ohgaki H; Kleihues P; Hard GC
Mol Carcinog; 1991; 4(6):455-9. PubMed ID: 1793484
[TBL] [Abstract][Full Text] [Related]
38. Gain of function in the mouse model of a recurrent mutation p53
Zhao L; Wang B; Zhao X; Wu X; Zhang Q; Wei C; Shi M; Li Y; Tang W; Zhang J; Yang J; Singh SK; Jia S; Luo Y
Mol Carcinog; 2018 Feb; 57(2):147-158. PubMed ID: 28949402
[TBL] [Abstract][Full Text] [Related]
39. Whole-Exome Sequencing of Acquired Nevi Identifies Mechanisms for Development and Maintenance of Benign Neoplasms.
Stark MS; Tan JM; Tom L; Jagirdar K; Lambie D; Schaider H; Soyer HP; Sturm RA
J Invest Dermatol; 2018 Jul; 138(7):1636-1644. PubMed ID: 29476775
[TBL] [Abstract][Full Text] [Related]
40. [Molecular biology of tobacco smoke associated neoplasia].
Zojer N; Fritsche R; Fiegl M; Schulte-Hermann R; Mannhalter C; Huber H
Wien Klin Wochenschr; 1996; 108(18):574-81. PubMed ID: 9012141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
